Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Hiab invests EUR 19 million on its Multilift demountables facility expansion in Raisio, Finland

Hiab Corporation HIAB CORPORATION, PRESS RELEASE, 15 MAY 2025 AT 3:00 PM (EEST) Hiab invests EUR 19 million on its Multilift demountables facility expansion in Raisio, Finland Hiab invests EUR 19 million to expand and modernise its Multilift demountables production facility in Raisio, Finland. …

EODHD | 16 May 2025

Goodyear Names Boucharlat to Lead Global Commercial Business

AKRON, Ohio, May 15, 2025 /PRNewswire/ -- The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced that Grégory Boucharlat has been named senior vice president, Global Commercial. In this new role, Grégory will join the company's senior leadership team, with responsibility for the …

EODHD | 16 May 2025

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

Ms. Doyle brings more than two decades of corporate strategy and business development experience across biotech, pharma, and venture ecosystems SAN DIEGO, May 15, 2025--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying …

EODHD | 16 May 2025

Lifeward Ltd. Reports First Quarter 2025 Financial Results

U.S. pipeline of ReWalk opportunities continues to build with over 120 qualified leads in process Closure of AlterG sites and resulting consolidation of resources and reduced expenditures yields improved operating expense trend Second consecutive quarter of AlterG revenue growth over 15% reflecting continued sales …

EODHD | 16 May 2025

Merus Announces the Journal Publication of Petosemtamab Mechanism of Action

Merus N.V. UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced publication on …

EODHD | 16 May 2025

OPKO Health to Participate in Two Upcoming Investor Conferences

OPKO Health, Inc. MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York …

EODHD | 16 May 2025

Blue Owl Capital Announces $7 Billion Final Close for Digital Infrastructure Fund

Blue Owl Digital Infrastructure Fund III seeks to support the global capital demands of hyperscalers, fueled by ongoing investments in data centers and artificial intelligence. NEW YORK, May 15, 2025 /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL), a leading alternative asset …

EODHD | 16 May 2025

Cathay Scales Up to Meet Increased Travel Demand with Enterprise AI and Automation from UiPath

Cathay Named UiPath AI25 Award Winner at UiPath FORWARD and is moving people forward in life with AI and automation HONG KONG, May 15, 2025--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced that it is helping Cathay, the Hong Kong-based …

EODHD | 16 May 2025

PennyMac Mortgage Investment Trust Declares Second Quarter 2025 Dividends for Its Preferred Shares

WESTLAKE VILLAGE, Calif., May 15, 2025--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that its Board of Trustees has declared cash dividends for the second quarter of 2025 on its 8.125% Series A Preferred Shares (NYSE: PMT PRA), its 8.000% Series B Preferred …

EODHD | 16 May 2025

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

SOUTH SAN FRANCISCO, Calif., May 15, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will present …

EODHD | 16 May 2025